The health impacts of endocrine disrupting chemicals (EDCs) remain debated and their tissue and molecular 21 targets are poorly understood. Here we leveraged systems biology approaches to assess the target tissues, 22 molecular pathways, and gene regulatory networks associated with prenatal exposure to the model EDC 23
Introduction

46
A central concept in the Developmental Origins of Health and Disease (DOHaD) states that adverse 47 environmental exposure during early developmental stages is an important determinant for later onset adverse 48 health outcomes, even in the absence of continuous exposure in adulthood [1] [2] [3] . BPA is one of the most 49 influential environmental metabolic disruptors identified to date with widespread exposure in human populations 50 and likely plays a role in DOHaD. BPA is used in the production of synthetic polymers, including epoxy resins 51 and polycarbonates [4] . The advantageous mechanical properties of BPA have resulted in its ubiquitous use in 52 everyday goods such as plastic bottles and inner coating of canned foods [5, 6] . BPA exposure has been confirmed 53 in the majority of human populations [7] and has been linked to body weight, obesity, insulin resistance, diabetes, 54 metabolic syndrome (MetS), and cardiovascular diseases in both human epidemiologic and animal studies [8] [9] [10] [11] [12] [13] [14] [15] . 55
Importantly, it has been suggested that the developing fetus is particularly vulnerable to BPA exposure [8, 16] . 56
Intrauterine growth retardation (IUGR) has been consistently observed after developmental BPA exposure at 57 intake doses below the suggested human safety level and has been associated with low birth weight, elevated 58 adult fat weight and altered glucose homeostasis [8, [17] [18] [19] [20] . As a result, BPA has been banned from baby products 59 in Europe, Canada, and the US. However, BPA is still in use in non-baby products, posing continuous exposure to 60 adults. Additionally, BPA has been associated with a transgenerational influence on obesity and MetS [21] [22] [23] , 61 contributing to a lingering effect of BPA exposure on future generations even under usage restriction. Together 62 7 uncover the epigenomic impact of prenatal BPA exposure at millions of methylation sites and analyzed the 115 connection of the epigenomic alterations to changes in the transcriptome. We then integrated the transcriptomic 116 and epigenomic signatures with two types of regulatory networks, namely, transcription factor networks to 117 identify perturbed TF hotspots, and gene regulatory networks to identify non-TF regulatory genes. Finally, we 118 interrogated the associations of the transcriptomic and epigenomic signatures of BPA obtained from our study 119 with metabolic phenotypes in our mouse offspring by correlative analysis, and with human diseases by querying 120 top reported candidate genes as well as full summary statistics from existing publicly available genome-wide 121 association studies (GWAS). 122
Mouse model of prenatal BPA exposure 123 Inbred C57BL/6 mice were maintained on a special diet 5V01 (LabDiet), certified to contain less than 150ppm 124 estrogenic isoflavones, and housed under standard housing conditions (room temperature 22-24°C) with 12:12 hr 125 light:dark cycle before mating at 8-10 weeks of age. Upon mating, female mice were randomly assigned to either 126 the BPA treatment group or the control group. From 1-day post-conception (dpc) to 20 dpc, BPA (Sigma-Aldrich, 127
St. Louis, MO) dissolved in corn oil was administered to pregnant female mice via oral gavage (mimicking 128 common exposure route in humans) at 5mg/kg/day on a daily basis. Control mice were fed the same amount of 129 empty vehicle. BPA exposure was restricted to experimental manipulation through the use of polycarbonate-free 130 8 (UC), triglyceride (TG), free fatty acid (FFA), and glucose were measured by enzymatic colorimetric assays at 138 UCLA GTM Mouse Transfer Core as previously described [40] . Gonadal white adipose tissue, hypothalamus, and 139 liver tissues were collected from each animal, flash frozen in liquid nitrogen, and stored at -80°C. For white 140 adipose tissue, we chose the gonadal depot mainly due to its similarity to abdominal fat, established relevance to 141 cardiometabolic risks, tissue abundance, and the fact that it is the most well-studied adipose tissue in mouse 142 models. All mouse experiments were conducted in accordance with and approved by the Institutional Animal 143
Care and Use Committee at University of California, Los Angeles. 144 RNA sequencing (RNA-seq) and data analysis 145 A total of 18 RNA samples were isolated from gonadal adipose, hypothalamus and liver tissues (n = 3 per group 146 per tissue; for each group, mice were randomly selected from litters of different dams in independent cages) from 147 male offspring using the AllPrep DNA/RNA Mini Kit (QIAGEN GmbH, Hilden, Germany). We focused on 148 profiling male tissues because of stronger phenotypes observed in males (Fig 1B-E) . Samples were processed for 149 library preparation using TruSeq RNA Library Preparation Kit (Illumina, San Diego, CA) for poly-A selection, 150 fragmentation, and reverse transcription using random hexamer-primers to generate first-strand cDNA. Second-151 strand cDNA was generated using RNase H and DNA polymerases, and sequencing adapters were ligated using 152 the Illumina Paired-End sample prep kit. Library products of 250-400bp fragments were isolated, amplified, and 153 sequenced with Illumina Hiseq2500 System. After quality control using FastQC [46], the HISAT-StringTie 154 pipeline [47] was used for sequence alignment and transcript assembly. Identification of differentially expressed 155 genes (DEGs) were conducted using DEseq2 [48] . To account for multiple testing, we used the q-value method 156
[49]. After excluding genes with extremely low expression levels (FPKM < 1), only DEGs demonstrating 157 differential expression comparing the BPA and control groups per tissue at a false discovery rate (FDR) < 5% 158 were used for biological pathway analysis, network analysis, and phenotypic data integration, as described below. 159 9 Reduced representation bisulfite sequencing (RRBS) and data analysis 160 We constructed RRBS libraries for 18 DNA samples from adipose, hypothalamus and liver tissues from male 161 offspring (n = 3 per group per tissue from the same set of tissues chosen for transcriptome analysis described 162 above). The DNA samples were quantified using the dsDNA BR assay (Qubit, Waltham, MA) and 100ng of DNA 163 was used for library preparation. After digestion of the DNA with the MspI enzyme, samples underwent an end-164 repair and adenylation process, followed by adapter ligation using the Truseq barcode adapter (Illumina, San 165 Diego, CA), size selection using AMPure Beads (Beckman Coulter, Brea, CA), and bisulfite treatment using the 166 Epitect Kit (Qiagen, Germantown, MD). Bisulfite-treated DNA was then amplified using the Truseq Library Prep 167 Kit (Illumina, San Diego, CA) and sequenced with the Illumina Hiseq2500 System. Bisulfite-converted reads 168 were processed and aligned to the reference mouse genome (GRCm38/mm10 build) using the bisulfite aligner 169 BSMAP [50] . We then used MOAB [51] for methylation ratio calling and identification of differentially 170 methylated CpGs (DMCs). FDR was estimated using the q-value approach. Loci with methylation level changes 171 of > 5% between BPA and control groups and FDR < 0.05 for each tissue were considered statistically significant 172 DMCs. To annotate the locations of the identified DMCs in relation to gene regions and repetitive DNA elements 173 accessed from UCSC genome browser, we used the Bioconductor package "annotatr" [52] . Specifically, gene 174 regions were categorized into 1) 1-5kb upstream of the transcription start site (TSS), 2) promoter (< 1kb upstream 175 of the TSS), 3) 5' untranslated region (UTR), 4) exons, 5) introns, and 6) 3'UTR. The "annotatr" package was 176 also used to annotate DMCs for known long non-coding RNAs (lncRNAs) based on GENCODE Release M16. 177
Over-representation of DMCs within each category was calculated using Fisher's exact test. We further evaluated 178 the link between DEGs and their local DMCs (DMCs annotated as any of the 6 above mentioned gene regions) by 179 correlating the methylation ratio of DMCs with the expression level of DEGs. 180 . In brief, we extracted the differential expression p-values of genes in 201 each pathway from the differential expression or methylation analyses and compared these p-values against the 202 null distribution of p-values from random gene sets with matching gene numbers. If genes in a given pathway 203 11 collectively show more significant differential expression or differential methylation p-values compared to 204 random genes based on a chi-square like statistic, we annotate the DEGs or DMCs using that pathway (S1 Text). 205
Pathway, network, and disease association analyses of DEGs and DMCs using the Mergeomics R
DEGs and DMCs can have multiple over-represented pathways. 206
Identification of transcription factor (TF) hotspots perturbed by BPA
207
To dissect the regulatory cascades of BPA, we first assessed whether BPA-associated DEGs were downstream 208 targets of specific transcription factors. The hypothesis behind this analysis is that BPA first affects TFs which in 209 turn regulate the expression of downstream genes. We used TF regulatory networks for adipose, brain, and liver 210 tissue retrieved from the FANTOM5 database [56] . Note that only a whole brain (instead of hypothalamus) TF 211 network was available, which may only partially represent hypothalamic gene regulation. Each TF network was 212 processed to keep the edges with high confidence (S1 Text). To identify TFs whose targets were perturbed by 213 BPA, the downstream nodes of each TF in the network were pooled as the target genes for that TF. We then 214 assessed the enrichment for BPA exposure related DEGs among the target genes of each TF using MSEA. TFs 215 with FDR < 5% were considered statistically significant. Cytoscape software was used for TF network 216 To further identify non-TF regulators that sense BPA and then perturb downstream genes, we used Bayesian 220 networks (BN) of adipose, hypothalamus and liver tissues constructed from genetic and transcriptomic data from 221 several large-scale mouse and human studies (S1 Text and S1 Table) . wKDA was used to identify network key 222 drivers (KDs), which are defined as network nodes whose neighboring subnetworks are significantly enriched for 223 BPA-associated DEGs. Briefly, wKDA takes gene set G (i.e. BPA DEGs) and directional gene network N (i.e. 224
BNs) as inputs. For every gene K in network N, neighboring genes within 1-edge distance were tested for 12 enrichment of genes in G using a chi-square like statistics followed by FDR assessment by permutation (S1 Text 226 and S2 Fig) . Network genes that reached FDR < 0.05 were reported as potential KDs. 227
Association of BPA DEGs and DMCs with mouse phenotypes and human diseases/traits
228 To assess whether the BPA molecular signatures were related to phenotypes examined in the mouse offspring, we 229 calculated the Pearson correlation coefficient among expression level of DEGs, methylation ratio of DMCs, and 230 the measurement of metabolic traits. For human diseases or traits, we accessed the GWAS catalog database [58] 231 and collected the lists of candidate genes reported to be associated with 161 human traits/diseases (P < 1e-5). 232
These genes were tested for enrichment of the BPA DEGs and DMCs in our mouse study using MSEA. We 233 further curated all publicly available full summary statistics for 61 human traits/diseases from various public 234 repositories (S1 Text and S2 Table) . This allowed us to apply MSEA to comprehensively assess the enrichment 235 for human disease association among BPA transcriptomic signatures using the full-spectrum of large-scale human 236 GWAS. For each tissue-specific gene signature, we used the SNPs within a 50kb chromosomal distance as the 237
representing SNPs for that gene. The trait/disease association p-values of the SNPs were then extracted from each 238 GWAS and compared to the p-values of SNPs of random sets of genes to assess whether the BPA signatures were 239 more likely to show stronger disease association in human GWAS (S1 Text and S1 Fig) . This strategy has been 240 successfully used in our previous animal model studies to assess the connection of genes affected by 241 environmental perturbations such as diets and trauma to various human diseases [40, 59] . 242 243 13
Results
244
Prenatal BPA exposure induces intrauterine growth retardation (IUGR) and alterations in 245 cardiometabolic phenotypes 246 We exposed pregnant C57BL/6 mice to BPA during gestation (day 1 to day 20 post-conception) at the dosage of 247 5mg/kg/day, and observed alterations in various metabolic phenotypes in the male and female offspring with 248 prenatal BPA exposure at the weaning age. Compared with the control group, both male and female offspring 249 from the BPA group showed significantly lower body weight, indicative of IUGR, a trait that is strongly 250 associated with later life insulin resistance and obesity risk (Fig 1B, D) . There were also significant decreases in 251 serum lipid parameters and an increase in serum glucose level in males (Fig 1C) , but not in females (Fig 1E) . The 252 decreases in the lipid parameters at this early developmental stage likely reflect the growth retardation phenotype 253 observed and may provide feedback signals to predispose the exposed offspring to lipid dysregulation later in life. 254
The phenotypic differences between BPA and control groups are not the results of litter effect, as offspring from 255 different dams in each group showed similar patterns (S3 Fig) . To explore the molecular basis underlying the potential health impact of prenatal BPA exposure, we collected 260 three core tissues important for metabolism from male offspring at 3 weeks. We focus on males due to the 261 stronger phenotypes observed. Hypothalamus is the central regulator of endocrine and metabolic systems, 262 whereas liver and white adipose tissues are critical for energy and metabolic homeostasis. We used RNA-seq to 263 profile the transcriptome, and identified 86, 93, and 855 differentially expressed genes (DEGs) in the adipose 264 tissue, hypothalamus, and liver tissue respectively, at FDR < 0.05 (Fig 2A, S3 Table) . This supports the ability of 265 14 prenatal BPA exposure to induce large-scale transcriptomic disruptions in offspring, with the impact appearing to 266 be more prominent in liver. The DEGs were highly tissue-specific, with only 12 out of the 86 adipose DEGs and 267 16 out of the 93 hypothalamus DEGs being found in liver. Interestingly, the hypothalamic DEGs are 268 predominantly up-regulated in the BPA group whereas the other two tissues did not show such direction bias (S4 269   Table) . Only one gene, Cyp51 (sterol 14-alpha demethylase), was shared across all three tissues but with different 270 directional changes (upregulated in hypothalamus and liver, downregulated in adipose) (Fig 2B) . S5 Table) . We observed strong enrichment for pathways related to lipid metabolism (lipid transport, 280 fatty acid metabolism, cholesterol biosynthesis) and energy metabolism (biological oxidation, TCA cycle) across 281 all three tissues. Most of these pathways appeared to be upregulated in all three tissues, with the exception of 282 downregulation of genes involved in biological oxidation in adipose tissue (Fig 2C-E) . Individual tissues also 283 showed perturbations of unique pathways: PPAR signaling and arachidonic acid pathways were altered in liver; 284 extracellular matrix related processes were enriched among hypothalamic DEGs; core histone genes were 285 upregulated in adipose DEGs (Fig 2C-E) . In addition, triglyceride biosynthesis and glucose metabolism pathways 286 were also moderately enriched among adipose DEGs, whereas few changes were seen for genes involved in (DMCs) were found in adipose, hypothalamus, and liver tissues, respectively (Fig 3A, S6 Table) . Interestingly, 294
BPA induced local methylation changes in Gm26917 and Yam1, two lncRNAs with no previously known link to 295 BPA, consistently across three tissues (Fig 3B) . The majority of the DMCs are located in intergenic regions (32% 296 -38%), followed by introns (31% -37%) and exons (13% -15%), but there is a paucity of DMCs in the promoter 297
Contrary to predictions that promoter regions may be more prone to epigenetic 298 changes, we found that within-gene and intergenic methylation alterations in DNA methylation are more 299 prevalent, a pattern consistently observed in previous epigenomic studies [40, 62] . In addition, 5.0%, 8.6%, and 300 8.1% DMCs overlap with repetitive DNA elements in adipose, hypothalamus, and liver, respectively, 301 recapitulating previous report of the interaction between BPA and repetitive DNA [63] . 302
For DMCs that are located within or adjacent to genes, we further tested whether the local genes adjacent to those 303 DMCs show enrichment for known functional categories. Unlike DEGs, top processes enriched for DMCs 304 concentrated on intra-and extra-cellular communication and signaling related pathways such as axon guidance, 305 extracellular matrix organization and NGF signaling (Fig 3C, full results in S7 Table) . The affected genes in 306 these processes are related to cellular structure, cell adhesion, and cell migration, indicating that these functions 307 may be particularly vulnerable to BPA induced epigenetic modulation. Fig and S8 Table) . These results support a role of BPA-induced differential methylation in altering 326 the expression levels of adjacent genes. 327 328 Pervasive influence of prenatal BPA exposure on the liver transcription factor network 329 BPA is known to bind to diverse types of nuclear receptors such as estrogen receptors and peroxisome 330 proliferator-activated (PPAR) receptors that function as transcription factors (TFs), thus influencing the action of 331 downstream genes [64, 65] . PPARg in particular has been shown to be a target of BPA in mouse and human and 332 mechanistically linking BPA exposure with its associated effect on weight gain and increased adipogenesis [66-333 68]. To explore the TF regulatory landscape underlying BPA exposure based on our genome-wide data, we 334 leveraged tissue-specific TF regulatory networks from the FANTOM5 project [56] and integrated it with our BPA 335 transcriptome profiling data. No TF was found to be differentially expressed in adipose tissue, whereas 1 TF 336 (Pou3f1) and 14 TFs (such as Esrra, Hnf1a, Pparg, Tcf21, Srebf1) were found to be differentially expressed in 337 hypothalamus and liver, respectively. Due to the temporal nature of TF action, changes in TF levels may precede 338 the downstream target genes and not be reflected in the transcriptomic profiles measured at the time of sacrifice. 339 Therefore, we further curated the target genes of TFs from FANTOM5 networks and tested the enrichment for the 340 target genes of each TF among our tissue-specific DEGs (S9 Table) . This analysis confirmed that BPA perturbs 341 the activity of the downstream targets for estrogen receptors Esrrg (p = 1.4e-3, FDR = 1.9%) and Esrra (p = 0.03, 342 FDR = 13%) in liver, as well as Esr1 in both adipose (p = 7.2e-3, FDR = 10.6%) and liver (p = 7.2e-3, FDR = 343 4.7%). Targets of Pparg were also perturbed in liver (p = 4.1e-3, FDR = 3.8%). Therefore, we demonstrated that 344 our data-driven network modeling is able to not only recapitulate results from previous in-vitro and in-vivo studies 345
showing that BPA influences estrogen signaling and PPAR signaling [65] , but also uniquely point to the tissue 346 specificity of these BPA target TFs. 347
In addition to these expected TFs, we identified 14 adipose TFs and 61 liver TFs whose target genes were 348 significantly enriched for BPA DEGs at FDR < 5%. Many of these TFs showed much stronger enrichment for 349 BPA DEGs among their downstream targets than the estrogen receptors (S9 Table) . We further extracted the subnetwork containing 89 unique downstream targets of the significant liver TFs that are 355 also liver DEGs. This subnetwork showed significant enrichment for genes involved in metabolic pathways such 356 18 as steroid hormone biosynthesis and fatty acid metabolism. The regulatory subnetwork for the top liver TFs (FDR 357 < 5%) revealed a highly interconnected TF subnetwork that potentially senses BPA exposure and in turn governs 358 the expression levels of their targets (Fig 4A) , with Pparg and Hnf4 among the core TFs. Some of the TFs in this 359 network, including Esr1, Esrrg, Foxp1, and Tcf7l1, also had local DMCs identified in our study, indicating that 360 BPA may perturb this liver TF subnetwork via local modification of DNA methylation of key TFs. 361 362
Identification of potential non-TF regulators governing BPA induced molecular perturbations 363
To further identify regulatory genes that mediate the action of BPA on downstream targets through non-TF 364 mechanisms, we leveraged data-driven tissue-specific Bayesian networks (BNs) generated from multiple 365 independent human and mouse studies (S1 Table) . These data-driven networks are complementary to the TF 366 networks used above and have proven valuable for accurately predicting gene-gene regulatory relationships and 367 novel key drivers (KDs) [39-42,70]. KDs were defined as network nodes whose surrounding subnetworks are 368 significantly enriched for BPA exposure related DEGs. At FDR < 1%, we identified 21, 1, and 100 KDs in 369 adipose, hypothalamus, and liver, respectively (S10 Table) . The top KDs in adipose (top 5 KDs Acss2, Pc, 370
Agpat2, Slc25a1, Acly), hypothalamus (Fa2h) and liver (top 5 KDs Dhcr7, Aldh3a2, Fdft1, Mtmr11, Hmgcr) were 371 involved in cholesterol, fatty acid and glucose metabolism processes. In addition, three KDs, Acss2 (Acetyl-372 Coenzyme A Synthetase 2), Acat2 (Acetyl-CoA Acetyltransferase 2), and Fasn (Fatty Acid Synthase), were 373 involved in the upregulation of DEGs in both adipose and liver, despite the fact that few DEG signatures overlap 374 across tissues (Fig 4B) . These KDs are consistent with the observed increased expression of several genes 375 implicated in lipogenesis, including Fasn, and help explain the liver accumulation of triglycerides when mice are 376 least one metabolic trait (Fig 5A, B) . Notably, liver DEGs exhibited stronger correlation with free fatty acid and 388 triglycerides, whereas adipose DEGs were uniquely associated with glucose level, which is consistent with the 389 pathway annotation results for these tissues. On the other hand, liver DMCs showed stronger correlations with 390 metabolic traits than those from adipose and hypothalamus tissues. 391
Cross-examination of correlation across gene expression, DNA methylation, and metabolic traits revealed 35 392 consistent DEG-DMC-trait associations (3 in adipose, 4 in hypothalamus, and 28 in liver) (S11 Table) . For 393 example, in adipose tissue, Fasn (also a perturbed TF hotspot in adipose, and a shared KD in adipose and liver) 394 was correlated with its exonic DMC at chr11:120816457, and both were correlated with triglyceride level; in 395 hypothalamus, Igf1r (Insulin Like Growth Factor 1 Receptor) was correlated with its intronic DMC at 396 chr7:68072768, and both were correlated with blood glucose level; in liver, Adh1 (Alcohol Dehydrogenase 1A) 397
was correlated with its intronic DMC at chr3:138287690, and both were correlated with body weight (Fig 5C) . we collected associated genes for 161 human traits/diseases (traits with fewer than 50 associated genes were 408 excluded), and evaluated the enrichment for the trait associated genes among DEG and DMC signatures. At FDR 409 < 5%, no trait was found to be significantly enriched for BPA DEGs. Surprisingly, despite the difference between 410 tissue-specific DMCs (Fig 3B) , 19 out the 161 traits showed consistently strong enrichment for DMCs across all 411 three tissues at FDR < 1%. The top traits include body mass index (BMI) and type 2 diabetes ( Table 1) . As DNA 412 methylation status is known to determine long-term gene expression pattern instead of immediate dynamic gene 413 regulation, the BMI and diabetes associated genes may be under long-term programming by BPA-induced 414 differential methylation, thereby affecting later disease risks. 415
The above analysis involving the GWAS catalog focused only on small sets of the top candidate genes for various 416 diseases and may have limited statistical power. To improve the statistical power, we curated the full summary 417 statistics from 61 human GWAS that are publicly available (covering millions of SNP-trait associations in each 418 GWAS), which enabled us to extend the assessment of disease association by considering additional human 419 disease genes with moderate to low effect sizes (Methods). This analysis showed that DEGs from all three tissues 420 exhibited consistent enrichment for genes associated with lipid traits such as triglycerides, LDL, and HDL ( Fig  421   6A-C) . Interestingly, enrichment for birth weight and birth length was also observed for hypothalamus and liver 422 signatures, respectively. Liver DEGs were also significantly associated with coronary artery disease, 423 inflammatory bowel disease, Alzheimer's disease, and schizophrenia. Top DEGs driving the inflammatory bowel 424 disease association involve immune and inflammatory response genes (PSMB9, TAP1, TNF), whereas association 425 21 with Alzheimer's disease and schizophrenia involve genes related to cholesterol homeostasis (APOA4, ABCG8, 426 SOAT2) and mitochondrial function (GCDH, PDPR, SHMT2), respectively. These results suggest that tissue-427 specific targets of BPA are connected to diverse human complex diseases through both the central nervous system 428 and peripheral tissues. FASN. Furthermore, the BPA gene signatures and the predicted regulators were found to be linked to a wide 442 spectrum of disease-related traits in both mouse and human. 443
The large-scale disruption we observed in the transcriptome and methylome in adipose and liver was consistent 444 with previous reports [32, 35, 73, 74] . For instance, comparison of our liver DEGs with the liver signatures 445 identified from meta-analysis of available GEO datasets showed significant overlap (P = 8.2e-3 by Fisher's exact 446 test, See S1 Text). However, our unique study design of examining multi-omics in multiple tissues in parallel 447 yields higher comparability when integrating the results between data types and across tissues, as they were from 448 22 the same set of animals and were profiled in the same conditions. Furthermore, our advanced multidimensional 449 integrative approach provides deeper insights into the regulatory cascades within and across tissues. Across all 450 three tissues at the transcriptome level, we found that lipid metabolism and energy homeostasis related processes 451 were consistently perturbed, with the scale of perturbation being strongest in liver. This aligns well with the 452 significant changes in the plasma lipid profiles we observed in the offspring, the reported perturbation of lipid 453 metabolism in fetal murine liver [74] , and the reported susceptibility for nonalcoholic fatty liver diseases 454 following BPA exposure [75-77]. The only shared gene across tissues, Cyp51, is involved in cholesterol and sterol 455 biosynthesis and beta oxidation, again supporting that metabolism is a central target of BPA. At the methylome 456 level, we are able to replicate 5 out of 7 peak hypomethylated genes, and 6 out of 9 peak hypermethylated genes 457 from a study focusing on the gonadal adipose tissue [35] . We also revealed an intriguing link between BPA and 458 lncRNAs across tissues, whose functional importance in developmental processes, disease progression, and 459 response to BPA exposure was increasingly recognized yet underexplored [78] . Our molecular data provides 460
intriguing lncRNA candidates such as Gm20319, Gm26917, and Yam1 for future in-depth functional analyses. 461
For adipose tissue, clusters of genes responsible for core histones were found to be uniquely altered. Along with 462 the strong adipose-specific differential methylation status, our results revealed gonadal adipose tissues as an 463 especially vulnerable site for BPA induced epigenetic reprogramming. Besides, developmental BPA exposure has 464 been previously suggested to influence white adipocyte differentiation [79] [80] [81] . However, the adipocyte 465 differentiation pathway was not significantly enriched in our study. This is consistent with the report by Angel et 466 al. [81] , where increased adipocyte number is only found in mouse offspring with prenatal BPA exposure at 467 5ug/kg/day and 500ug/kg/day, but not 5mg/kg/day. Additionally, we found significant changes in triglyceride 468 biosynthesis and glucose metabolism genes, suggesting that prenatal BPA exposure affects fat storage and glucose 469 homeostasis in the adipose tissue. Although here we mainly investigate gonadal adipose tissue as a surrogate for 470 abdominal fat in the context of metabolic disorders, the information may be useful for exploring the relationship 471 between this fat depot and the gonad. 472 23 With regards to the hypothalamus, our study is the first to investigate the effect of BPA on the hypothalamic 473 transcriptome and DNA methylome. Hypothalamus is an essential brain region that regulates the endocrine 474 system, peripheral metabolism, and numerous brain functions. We identified BPA-induced DEGs and DMCs that 475 were enriched for extracellular matrix related processes such as axon guidance, focal adhesion, and various 476 metabolic processes. These hypothalamic pathways have been previously associated with metabolic [40, 41] and 477 neurodegenerative diseases [40, 82] , and they could underlie the reported disruption of hypothalamic melanocortin 478 circuitry after BPA exposure [83] . Our study highlights the hypothalamus as another critical yet under-recognized 479 target for BPA. 480
By interrogating both the transcriptome and DNA methylome in matching tissues, we were able to directly assess 481 both global and specific correlative relationships between DEGs and DMCs (S6 Fig, Fig 3D) . Specifically, we 482 found that DEGs are more likely to have correlated DMCs in the matching tissue, a trend that persists in non-483 promoter regions. Our results corroborate previous findings regarding the importance of gene body methylation in 484 disease etiology [84, 85] . Given that over 90% of DMCs were found in non-promoter regions, closer investigation 485 of the regulatory circuits involving these regions may unveil new insights into BPA response [62] . 486
Known as an endocrine disrupting chemical, BPA has been speculated to exert its primary biological action by 487 modifying the activity of hormone receptors, including estrogen receptors, PPARg and glucocorticoid receptors 488 [65] . Indeed, the activity for the downstream targets of Pparg and three estrogen and estrogen-related receptors 489 were found to be disrupted in liver by prenatal BPA exposure. More importantly, our unbiased data-driven 490 analysis revealed many novel transcription factors and non-TF regulatory genes that also likely mediate BPA 491 effects. In fact, many of the newly identified TF targets of BPA, such as Fasn and several hepatic nuclear factors, 492 showed much higher ranking in our regulator prediction analyses. In liver, a tightly inter-connected TF 493 subnetwork was highly concentrated with BPA affected genes involved in metabolic processes such as 494 cytochrome P450 system (Cyp3a25, Cyp2a12, Cyp1a2), lipid (Apoa4, Abcg5, Soat2) and glucose (Hnf1a, 495
Adra1b, Gck) regulation, with extensive footprints of altered methylation status in the TFs and other subnetwork 496 genes (Fig 4A) . Therefore, our results support a widespread impact of BPA on liver transcriptional regulation, and 497 the convergence of differential methylation and gene expression in this TF subnetwork implies that BPA perturbs 498 this subnetwork via epigenetic regulation of the TFs, which in turn trigger transcriptomic alterations in 499 downstream genes. In adipose, we discovered a regulatory axis governed by Nfya and Fasn that are known 500 regulators of fatty acid metabolism and adipogenesis. NF-YA is a histone-fold domain protein that binds to the 501 inverted CCAAT element in the Fasn promoter [69,86], and both Nfya and Fasn were found to significantly 502 perturbed by BPA in our study. Moreover, Fasn also serves as a cross-tissue KD, governing distinct groups of up-503 regulated lipid metabolism genes in adipose and liver post-BPA exposure (Fig 4B) , supporting its role in 504 mediating the BPA-induced lipid dysregulation at the systemic level. The significant correlation of gene 505 expression and methylation for Fasn with triglyceride level furthers implicates its role as a network-level 506 regulator and biomarker for BPA induced lipid dysregulation. Our observation of Fasn is consistent with 507 evidences suggesting its susceptibility to methylation perturbation under obesogenic feeding [87] and its causal 508 functional importance for fatty liver diseases [42, 88] . These novel regulators warrant future experimental testing 509 of their causal regulatory role in BPA activities via genetic manipulation studies, such as knocking down or 510 overexpressing Fasn to examine the modulation of BPA activities. 511
One unique aspect of this study is the linking of the molecular landscape of prenatal BPA exposure to 512 traits/diseases in both mouse and human. In our mouse study, the observed changes in body weight, lipid profiles, 513 and glucose level are highly concordant with the functions of the molecular targets. For instance, prenatal BPA 514 exposure perturbs both the expression levels and the local DNA methylation status of Fasn, Igf1r, and Adh1. 515
These DEGs and their local DMCs also significantly correlate with phenotypic outcomes, thus serving as 516 examples of how DNA methylation and gene regulation bridge the gap between BPA exposure and phenotypic 517 manifestation. To further enhance the translatability of our findings from mouse to human, we searched for 518 human diseases linked to the BPA-affected genes. An intriguing discovery is the prominent overrepresentation of 519 differential methylation signals in adipose, hypothalamus, and liver within known genes related to obesity and 520 25 type 2 diabetes, supporting that BPA may impact obesity and diabetes risk through systemic reprogramming of 521 DNA methylation. More sophisticated analysis incorporating the BPA differential gene expression and the full 522 statistics of human genome-wide association studies corroborated the observed connection between prenatal BPA 523 exposure and lipid homeostasis [89], birth weight [90], and coronary artery disease [14] reported in observational 524 studies. Moreover, our findings suggest the involvement of prenatal BPA exposure in the development of 525 inflammatory bowel syndrome, schizophrenia, and Alzheimer's disease. These associations warrant future 526 investigations. 527
One limitation of our work is the restriction of study scope to weaning age male mice with in utero BPA exposure 528 below the NOAEL (5mg/kg/d) as a proof-of-concept for our systems biology framework. Considering that the 529 effects of early-life exposure to BPA is highly variable and dependent on factors such as the dose, window, route, 530 and frequency of exposure as well as genetic background, age, and sex [13], future studies testing these additional 531 variables are necessary to generate a comprehensive understandings of BPA risks under various exposure 532 conditions. 533
Conclusions
534
Our study represents the first multi-tissue, multi-omics integrative investigation of prenatal BPA exposure. The 535 systems biology framework we applied revealed how BPA triggers cascades of regulatory circuits involving 536 numerous transcription factors and non-TF regulators that coordinate diverse molecular processes within and 537 across core metabolic tissues, thereby highlighting that BPA exerts its biological functions via much more diverse 538 targets than previously thought. As such, our findings offer a comprehensive systems-level understanding of 539 tissue sensitivity and molecular perturbations elicited by prenatal BPA exposure, and offer promising novel 540 candidates for targeted mechanistic investigation as well as much-needed network-level biomarkers of prior BPA 541 exposure. The strong influence of BPA on metabolic pathways and cardiometabolic phenotypes merits it 542 characterization as a general metabolic disruptor posing systemic health risks. 543 26 544 Tables   788   Table 1 . Top 5 human traits whose associated genes in genome-wide association studies are enriched for 789 differentially methylated CpGs (DMCs) across adipose, hypothalamus and liver at FDR < 1% in MSEA. 790 Pair-wise correlation between expression level, methylation ratio and metabolic profiles (triglyceride, glucose 827 level, body weight) for Fasn, Igf1r and Adh1. P_cor, p-value was determined using Pearson correction test; 828 P_DEG was determined using differential expression test; P_DMC was determined using differential methylation 829 test. 830 48 831
Human trait
Fig 6. Association of differential expression signatures from adipose (A), hypothalamus (B) and liver (C) 832
with 61 human traits/diseases, color coded into nine primary categories. P-values are determined using 833 MSEA. Red dashed line indicates the cutoff for Bonferroni-corrected p = 0.05. Names of traits/diseases whose p-834 values didn't pass Bonferroni-corrected cutoff were not shown. 835
